Crossref
journal-article
Springer Science and Business Media LLC
Nature (297)
References
30
Referenced
1,541
-
The ADHR Consortium. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nature Genet. 26, 345–348 (2000)
(
10.1038/81664
) -
Shimada, T. et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc. Natl Acad. Sci. USA 98, 6500–6505 (2001)
(
10.1073/pnas.101545198
) / Proc. Natl Acad. Sci. USA by T Shimada (2001) -
Itoh, N. & Ornitz, D. M. Evolution of the Fgf and Fgfr gene families. Trends Genet. 20, 563–569 (2004)
(
10.1016/j.tig.2004.08.007
) / Trends Genet. by N Itoh (2004) -
Yamazaki, Y. et al. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J. Clin. Endocrinol. Metab. 87, 4957–4960 (2002)
(
10.1210/jc.2002-021105
) / J. Clin. Endocrinol. Metab. by Y Yamazaki (2002) -
Jonsson, K. B. et al. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N. Engl. J. Med. 348, 1656–1663 (2003)
(
10.1056/NEJMoa020881
) / N. Engl. J. Med. by KB Jonsson (2003) -
Shimada, T. et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J. Bone Miner. Res. 19, 429–435 (2004)
(
10.1359/JBMR.0301264
) / J. Bone Miner. Res. by T Shimada (2004) -
Kuro-o, M. et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390, 45–51 (1997)
(
10.1038/36285
) / Nature by M Kuro-o (1997) -
Riminucci, M. et al. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J. Clin. Invest. 112, 683–692 (2003)
(
10.1172/JCI18399
) / J. Clin. Invest. by M Riminucci (2003) -
Murer, H., Hernando, N., Forster, I. & Biber, J. Proximal tubular phosphate reabsorption: molecular mechanisms. Physiol. Rev. 80, 1373–1409 (2000)
(
10.1152/physrev.2000.80.4.1373
) / Physiol. Rev. by H Murer (2000) -
Wikvall, K. Cytochrome P450 enzymes in the bioactivation of vitamin D to its hormonal form. Int. J. Mol. Med. 7, 201–209 (2001)
(
10.1007/s008940100035
) / Int. J. Mol. Med. by K Wikvall (2001) -
Gashler, A. & Sukhatme, V. P. Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog. Nucleic Acid Res. Mol. Biol. 50, 191–224 (1995)
(
10.1016/S0079-6603(08)60815-6
) / Prog. Nucleic Acid Res. Mol. Biol. by A Gashler (1995) -
Liu, L., Tsai, J. C. & Aird, W. C. Egr-1 gene is induced by the systemic administration of the vascular endothelial growth factor and the epidermal growth factor. Blood 96, 1772–1781 (2000)
(
10.1182/blood.V96.5.1772
) / Blood by L Liu (2000) -
Nabeshima, Y. Klotho: a fundamental regulator of aging. Ageing Res. Rev. 1, 627–638 (2002)
(
10.1016/S1568-1637(02)00027-2
) / Ageing Res. Rev. by Y Nabeshima (2002) -
Imura, A. et al. Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane. FEBS Lett. 565, 143–147 (2004)
(
10.1016/j.febslet.2004.03.090
) / FEBS Lett. by A Imura (2004) -
Yu, X. et al. Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23. Endocrinology 146, 4647–4656 (2005)
(
10.1210/en.2005-0670
) / Endocrinology by X Yu (2005) -
Yamashita, T., Konishi, M., Miyake, A., Inui, K. & Itoh, N. Fibroblast growth factor (FGF)-23 inhibits renal phosphate reabsorption by activation of the mitogen-activated protein kinase pathway. J. Biol. Chem. 277, 28265–28270 (2002)
(
10.1074/jbc.M202527200
) / J. Biol. Chem. by T Yamashita (2002) -
Christy, B. A., Lau, L. F. & Nathans, D. A gene activated in mouse 3T3 cells by serum growth factors encodes a protein with ‘zinc finger’ sequences. Proc. Natl Acad. Sci. USA 85, 7857–7861 (1988)
(
10.1073/pnas.85.21.7857
) / Proc. Natl Acad. Sci. USA by BA Christy (1988) -
Shimada, T. et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J. Clin. Invest. 113, 561–568 (2004)
(
10.1172/JCI200419081
) / J. Clin. Invest. by T Shimada (2004) -
Sitara, D. et al. Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol. 23, 421–432 (2004)
(
10.1016/j.matbio.2004.09.007
) / Matrix Biol. by D Sitara (2004) -
Yoshida, T., Fujimori, T. & Nabeshima, Y. Mediation of unusually high concentrations of 1,25-dihydroxyvitamin D in homozygous klotho mutant mice by increased expression of renal 1α-hydroxylase gene. Endocrinology 143, 683–689 (2002)
(
10.1210/endo.143.2.8657
) / Endocrinology by T Yoshida (2002) -
Tsujikawa, H., Kurotaki, Y., Fujimori, T., Fukuda, K. & Nabeshima, Y. Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol. Endocrinol. 17, 2393–2403 (2003)
(
10.1210/me.2003-0048
) / Mol. Endocrinol. by H Tsujikawa (2003) -
Larsson, T., Nisbeth, U., Ljunggren, O., Juppner, H. & Jonsson, K. B. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int. 64, 2272–2279 (2003)
(
10.1046/j.1523-1755.2003.00328.x
) / Kidney Int. by T Larsson (2003) -
Vainikka, S. et al. Signal transduction by fibroblast growth factor receptor-4 (FGFR-4). Comparison with FGFR-1. J. Biol. Chem. 269, 18320–18326 (1994)
(
10.1016/S0021-9258(17)32309-8
) / J. Biol. Chem. by S Vainikka (1994) -
Ornitz, D. M. & Itoh, N. Fibroblast growth factors. Genome Biol. 2, 3005.1–3005.12 (2001)
(
10.1186/gb-2001-2-3-reviews3005
) / Genome Biol. by DM Ornitz (2001) -
Ito, S. et al. Molecular cloning and expression analyses of mouse betaklotho, which encodes a novel Klotho family protein. Mech. Dev. 98, 115–119 (2000)
(
10.1016/S0925-4773(00)00439-1
) / Mech. Dev. by S Ito (2000) -
Ito, S., Fujimori, T., Hayashizaki, Y. & Nabeshima, Y. Identification of a novel mouse membrane-bound family 1 glycosidase-like protein, which carries an atypical active site structure. Biochim. Biophys. Acta 1576, 341–345 (2002)
(
10.1016/S0167-4781(02)00281-6
) / Biochim. Biophys. Acta by S Ito (2002) -
Holt, J. A. et al. Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev. 17, 1581–1591 (2003)
(
10.1101/gad.1083503
) / Genes Dev. by JA Holt (2003) -
Kharitonenkov, A. et al. FGF-21 as a novel metabolic regulator. J. Clin. Invest. 115, 1627–1635 (2005)
(
10.1172/JCI23606
) / J. Clin. Invest. by A Kharitonenkov (2005) -
Ito, S. et al. Impaired negative feedback suppression of bile acid synthesis in mice lacking betaKlotho. J. Clin. Invest. 115, 2202–2208 (2005)
(
10.1172/JCI23076
) / J. Clin. Invest. by S Ito (2005) -
Shimada, T. et al. Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo.. Endocrinology 143, 3179–3182 (2002)
(
10.1210/endo.143.8.8795
) / Endocrinology by T Shimada (2002)
Dates
Type | When |
---|---|
Created | 18 years, 9 months ago (Nov. 8, 2006, 4:28 a.m.) |
Deposited | 2 years, 3 months ago (May 18, 2023, 2 p.m.) |
Indexed | 3 days, 10 hours ago (Aug. 28, 2025, 8:40 a.m.) |
Issued | 18 years, 10 months ago (Oct. 29, 2006) |
Published | 18 years, 10 months ago (Oct. 29, 2006) |
Published Online | 18 years, 10 months ago (Oct. 29, 2006) |
Published Print | 18 years, 8 months ago (Dec. 1, 2006) |
@article{Urakawa_2006, title={Klotho converts canonical FGF receptor into a specific receptor for FGF23}, volume={444}, ISSN={1476-4687}, url={http://dx.doi.org/10.1038/nature05315}, DOI={10.1038/nature05315}, number={7120}, journal={Nature}, publisher={Springer Science and Business Media LLC}, author={Urakawa, Itaru and Yamazaki, Yuji and Shimada, Takashi and Iijima, Kousuke and Hasegawa, Hisashi and Okawa, Katsuya and Fujita, Toshiro and Fukumoto, Seiji and Yamashita, Takeyoshi}, year={2006}, month=oct, pages={770–774} }